References
1. Konstantinova N.A. Cryoglobulins and pathology. Moscow: Меditsina, 1999: 175 p. ISBN 5-225-02773-3 (in Russian)
2. Pascual M., Perrin L., Giostra E., Schifferli J.A. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis. 1990; 162 (2): 569–70. DOI: https://doi.org/10.1093/infdis/162.2.569
3. Stricker R.B., Sanders K.A., Owen W.F., et al. Mononeuritis multiplex associated with cryoglobulinemia in HIV infection. Neurology. 1992; 42 (11): 2103–5. DOI: https://doi.org/10.1212/wnl.42.11.2103
4. Gherardi R., Belec L., Mhiri C., et al. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis Rheum. 1993; 36 (8): 1164–74. DOI: https://doi.org/10.1002/art.1780360818
5. Viganò M., Lampertico P., Rumi M.G., et al. Natural history and clinical impact of cryoglobulins in chronic hepatitis C: 10-year prospective study of 343 patients. Gastroenterology. 2007; 133 (3): 835–42. DOI: https://doi.org/10.1053/j.gastro.2007.06.064
6. Minopetrou M., Hadziyannis E., Deutsch M., et al. Hepatitis C virus (HCV)-related cryoglobulinemia: cryoglobulin type and anti-HCV profile. Clin Vaccine Immunol. 2013; 20 (5): 698–703. DOI: https://doi.org/10.1128/CVI.00720-12
7. Aguiar M.F., Faria-Janes A.L., Garcia-Brandes G.I., et al. Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients. Ann Hepatol. 2019; 18 (5): 685–92. DOI: https://doi.org/10.1016/j.aohep.2019.04.010
8. Clinical recommendations “HIV infection in adults”. 2020. URL: https://cr.minzdrav.gov.ru/recomend/79_1 (in Russian)
9. Neustroeva Iu.A., Tikhomirova T.A., Dunaeva N.V., et al. Optimization of semiquantitative method for detection of cryoglobulins in a clinical diagnostic laboratory. Klinicheskaya laboratornaya diagnostika [Clinical Laboratory Diagnostics]. 2007; (1): 37–41. PMID: 17385441. (in Russian)
10. Kayali Z., Buckwold V.E., Zimmerman B., Schmidt W.N. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology. 2002; 36 (4 Pt 1): 978–85. DOI: https://doi.org/10.1053/jhep.2002.35620
11. Cacoub P., Renou C., Rosenthal E., et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore). 2000; 79 (1): 47–56. DOI: https://doi.org/10.1097/00005792-200001000-00005
12. Scotto G., Cibelli D.C., Saracino A., et al. Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection. J Infect. 2006; 52 (4): 294–9. DOI: https://doi.org/10.1016/j.jinf.2005.05.025
13. Lapinski T.W., Parfieniuk A., Rogalska-Plonska M., et al. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function. Liver Int. 2009; 29 (8): 1158–61. DOI: https://doi.org/10.1111/j.1478-3231.2009.02052.x
14. Rogalska-Płońska M., Lapinski T.W., Grzeszczuk A., et al. Influence of HCV and HIV on development of cryoglobulinemia. Viral Immunol. 2015; 28 (3): 145–52. DOI: https://doi.org/10.1089/vim.2014.0114
15. Dunaeva N.V., Gezey M.A., Mazing A.V., et al. The mixed cryoglobulinemia among patients with HIV or HIV/HCV and a chronic kidney disease. Nefrologiya i dializ [Nephrology and Dialysis]. 2019; 21 (1): 49–57. DOI: https://doi.org/10.28996/2618-9801-2019-1-49-57 (in Russian)
16. Dunaeva N.V., Neustroeva Yu.A., Tikhomirova T.A., et al. Prevalence and risk factors in development of chronic hepatitis C-associated cryoglobulinemia. Meditsinskaya immunologiya [Medical Immunology]. 2007: 9 (6): 575–80. (in Russian)
17. Milovanova S.Yu., Kozlovskaya L.V., Gordovskaya N.B. Polymorphism of clinical manifestations of cryoglobulinemic hepatitis associated with chronic hepatitis C. Al’manakh klinicheskoy meditsiny [Almanac of Clinical Medicine]. 2014; (30): 46–51 (in Russian)
18. Antonescu C., Mayerat C., Mantegani A., et al. Hepatitis C virus (HCV) infection: serum rheumatoid factor activity and HCV genotype correlate with cryoglobulin clonality. Blood. 1998; 92 (9): 3486–7. PMID: 9787197.
19. Pawlotsky J.M., Ben Yahia M., Andre C., et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology. 1994; 19 (4): 841–8. PMID: 8138255.
20. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol. 1997; 19 (1): 111–29. DOI: https://doi.org/10.1007/BF00945029 PMID: 9266635
21. Chang M.L., Chang S.W., Chen S.C., et al. Genetic association of hepatitis c-related mixed cryoglobulinemia: a 10-year prospective study of Asians treated with antivirals. Viruses. 2021; 13 (3): 464. DOI: https://doi.org/10.3390/v13030464
22. Brouet J.C., Clauvel J.P., Danon F., et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974; 57 (5): 775–88. DOI: https://doi.org/10.1016/0002-9343(74)90852-3
23. Pontet F., Halimi C., Brocard A., Delacour T. Biclonal immunoglobulin M dysglobulinaemia: evolving aspects in a case of primary Sjögren’s syndrome. Eur J Clin Chem Clin Biochem. 1997; 35 (4): 287–90. DOI: https://doi.org/10.1515/cclm.1997.35.4.287
24. Sansonno D., Carbone A., De Re V., Dammacco F. Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford). 2007; 46 (4): 572–8. DOI: https://doi.org/10.1093/rheumatology/kel425
25. Della Rossa A., Tavoni A., D’Ascanio A., et al. Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus. Scand J Rheumatol. 2010; 39 (2): 167–70. DOI: https://doi.org/10.3109/03009740903313639
26. Ramos-Casals M., Forns X., Brito-Zerón P., et al. Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection. J Viral Hepat. 2007; 14 (10): 736–42. DOI: https://doi.org/10.1111/j.1365-2893.2007.00866.x
27. Dimitrakopoulos A.N., Kordossis T., Hatzakis A., Moutsopoulos H.M. Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med. 1999; 130 (3): 226–30. DOI: https://doi.org/10.7326/0003-4819-130-3-199902020-00027
28. Kordossis T., Sipsas N.V., Kontos A., et al. Mixed cryoglobulinemia is associated with increased risk for death, or neoplasia in HIV-1 infection. Eur J Clin Invest. 2001; 31 (12): 1078–82. DOI: https://doi.org/10.1046/j.1365-2362.2001.00934.x